FDA Approved: PREZCOBIX — Supplemental Application (Janssen Products, LP)

View source ↗

Summary

FDA approved a supplemental application for PREZCOBIX (darunavir ethanolate and cobicistat), updating the labeling for this HIV-1 infection therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• PREZCOBIX (darunavir ethanolate and cobicistat)

Snippet

SUPPL AP for PREZCOBIX (DARUNAVIR ETHANOLATE AND COBICISTAT)